Mycolactone-Dependent Depletion of Endothelial Cell Thrombomodulin Is Strongly Associated with Fibrin Deposition in Buruli Ulcer Lesions

Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease

(2014) Fred S Sarfo et al.   BMC INFECTIOUS DISEASES

The MyD88+ Phenotype Is an Adverse Prognostic Factor in Epithelial Ovarian Cancer

(2014) Charles J. d'Adhemar et al.   PLoS One

Immunohistochemical Monitoring of Wound Healing in Antibiotic Treated Buruli Ulcer Patients

(2014) Arianna Andreoli et al.   PLoS Neglected Tropical Diseases

The Pathogenic Mechanism of the Mycobacterium ulcerans Virulence Factor, Mycolactone, Depends on Blockade of Protein Translocation into the ER

(2014) Belinda S. Hall et al.   PLoS Pathogens

Clinical and Bacteriological Efficacy of Rifampin-Streptomycin Combination for Two Weeks followed by Rifampin and Clarithromycin for Six Weeks for Treatment of Mycobacterium ulcerans Disease

(2013) Richard O. Phillips et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Association of the Thrombomodulin Gene c.1418C>T Polymorphism With Thrombomodulin Levels and With Venous Thrombosis Risk

(2013) Silvia Navarro et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African children

(2013) C. A. Moxon et al.   BLOOD

Identifying the Achilles heel of multi-host pathogens: the concept of keystone ‘host’ species illustrated byMycobacterium ulceranstransmission

(2013) Benjamin Roche et al.   Environmental Research Letters

Mycolactone activation of Wiskott-Aldrich syndrome proteins underpins Buruli ulcer formation

(2013) Laure Guenin-Macé et al.   JOURNAL OF CLINICAL INVESTIGATION

Thrombomodulin Regulates Keratinocyte Differentiation and Promotes Wound Healing

(2013) Tsung-Lin Cheng et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

History, biology and chemistry of Mycobacterium ulcerans infections (Buruli ulcer disease)

(2013) Anne-Caroline Chany et al.   NATURAL PRODUCT REPORTS

Secondary Bacterial Infections of Buruli Ulcer Lesions Before and After Chemotherapy with Streptomycin and Rifampicin

(2013) Dorothy Yeboah-Manu et al.   PLoS Neglected Tropical Diseases

Mycobacterium ulceransinfection: evolution in clinical management

(2012) Candice Simpson et al.   ANZ JOURNAL OF SURGERY

Gap Junctions and Connexin Hemichannels Underpin Hemostasis and Thrombosis

(2012) Sakthivel Vaiyapuri et al.   CIRCULATION

Thrombomodulin is an ezrin-interacting protein that controls epithelial morphology and promotes collective cell migration

(2012) Yun-Yan Hsu et al.   FASEB JOURNAL

Apoptosis in Buruli ulcer: a clinicopathological study of 45 cases

(2012) Elisa Zavattaro et al.   HISTOPATHOLOGY

Rhinocetin, a Venom-derived Integrin-specific Antagonist Inhibits Collagen-induced Platelet and Endothelial Cell Functions

(2012) Sakthivel Vaiyapuri et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Chemotherapy-Associated Changes of Histopathological Features of Mycobacterium ulcerans Lesions in a Buruli Ulcer Mouse Model

(2011) Marie-Thérèse Ruf et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activated protein C cofactor function of protein S: a novel role for a  -carboxyglutamic acid residue

(2011) J. Ahnstrom et al.   BLOOD

Paradoxical Responses After Start of Antimicrobial Treatment in Mycobacterium ulcerans Infection

(2011) W. A. Nienhuis et al.   CLINICAL INFECTIOUS DISEASES

TreatingMycobacterium ulceransdisease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

(2011) Paul J Converse et al.   Future Microbiology

Endothelium—role in regulation of coagulation and inflammation

(2011) Victor W. M. van Hinsbergh   Seminars in Immunopathology

Protein C anticoagulant system—anti-inflammatory effects

(2011) Charles T. Esmon   Seminars in Immunopathology

Mycolactone Diffuses into the Peripheral Blood of Buruli Ulcer Patients - Implications for Diagnosis and Disease Monitoring

(2011) Fred S. Sarfo et al.   PLoS Neglected Tropical Diseases

Histopathological Changes and Clinical Responses of Buruli Ulcer Plaque Lesions during Chemotherapy: A Role for Surgical Removal of Necrotic Tissue?

(2011) Marie-Thérèse Ruf et al.   PLoS Neglected Tropical Diseases

Secondary Buruli Ulcer Skin Lesions Emerging Several Months after Completion of Chemotherapy: Paradoxical Reaction or Evidence for Immune Protection?

(2011) Marie-Thérèse Ruf et al.   PLoS Neglected Tropical Diseases

Buruli Ulcer: Advances in Understanding Mycobacterium ulcerans Infection

(2010) Douglas S. Walsh et al.   DERMATOLOGIC CLINICS

A Mycobacterium ulcerans toxin, mycolactone, induces apoptosis in primary human keratinocytes and in HaCaT cells

(2010) Chiarella Bozzo et al.   MICROBES AND INFECTION

Ecology and Transmission of Buruli Ulcer Disease: A Systematic Review

(2010) Richard W. Merritt et al.   PLoS Neglected Tropical Diseases

Immunosuppression and treatment-associated inflammatory response in patients withMycobacterium ulceransinfection (Buruli ulcer)

(2009) Daniela Schütte et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Mycolactone Inhibits Monocyte Cytokine Production by a Posttranscriptional Mechanism

(2009) R. E. Simmonds et al.   JOURNAL OF IMMUNOLOGY

Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer

(2009) Manuel T Silva et al.   LANCET INFECTIOUS DISEASES